Show simple item record

dc.creatorBohrer, Robert A.en
dc.date.accessioned2016-01-08T21:45:44Zen
dc.date.available2016-01-08T21:45:44Zen
dc.date.created2000en
dc.date.issued2000en
dc.identifierdoi:10.1002/0471250597en
dc.identifier.bibliographicCitationIn: Murray, Thomas H.; Mehlman, Maxwell J., eds. Encyclopedia of Ethical, Legal, Policy Issues in Biotechnology. 2 vols. New York: John Wiley & Sons; 2000: 266-274.en
dc.identifier.urihttp://dx.doi.org/10.1002/0471250597en
dc.identifier.urihttp://hdl.handle.net/10822/930658en
dc.formatBook Chapteren
dc.languageenen
dc.sourceeweb:212006en
dc.subjectBiotechnologyen
dc.subjectRegulationen
dc.subject.classificationScience, Technology, and Societyen
dc.subject.classificationSocial Control of Science and Technologyen
dc.subject.classificationDrugs and Drug Industryen
dc.titleFederal Regulation of Biotechnology Products for Human Use, FDA, Orphan Drug Acten
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2023 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885